Scientists at Sanaria and Seattle Children’s Research Institute’s Center for Global Infectious Disease Research (CGIDR) have unveiled a groundbreaking malaria vaccine, Sanaria^® PfSPZ-LARC2 Vaccine, designed to provide high-level protection with just one dose. This innovative approach leverages decades of research and cutting-edge genetic engineering to combat one of the world’s deadliest diseases.

Can telemedicine and exercise apps improve the health of people with type 2 diabetes and coronary heart disease? A large study led by the Technical University of Munich (TUM) shows that the positive effects are minimal. Study leader Prof. Martin Halle views the results as clear evidence of misplaced priorities in medical care. Direct care from medical professionals remains crucial.

Have you ever seen a label accompanying a product that says it contains chemicals “known to the State of California” that could cause harm? That’s thanks to a law nicknamed Proposition 65, which gives Californians the right to know whether they might be exposed to certain chemicals. Researchers publishing in ACS’ Environmental Science & Technology show that Proposition 65 has influenced manufacturers, too, by encouraging them to reformulate their products.

A team of researchers at the University of Konstanz has succeeded in adapting an AI system to reliably assist with making nanoparticle measurements which speeds up the research process significantly.